Concepedia

Peter Rieckmann

PR

Statistics

Publications

4

Citations

567

H-Index

4

Active since

2001

Affiliations

Heinrich Heine University Düsseldorf(Current)

Peter Rieckmann is an author at Heinrich Heine University Düsseldorf specializing in multiple sclerosis pharmacotherapy, multiple sclerosis, and neuroimmunology.

ORCID

Publications per year

2001–2022

4

Publications

4

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

G. Francis, Richard AC Hughes, John King et al. · DIAL (Catholic University of Leuven) · 2001 · 472 citations

, , +8

Multiple Sclerosis Therapy Consensus Group (MSTCG) Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations

Heinz Wiendl, Klaus V. Toyka, Peter Rieckmann et al. · 2008 · 58 citations

, , +17

Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4

Sven G. Meuth, Antonios Bayas, Boris Kallmann et al. · Expert Opinion on Pharmacotherapy · 2022 · 27 citations · Full text

, , +17

Effects of cladribine tablets on peripheral lymphocyte subtypes implicated in multiple sclerosis immunopathogenesis: surface marker analysis for a subset of patients from the 96-week, phase III, double-blind, placebo-controlled CLARITY study

Peter Rieckmann, G. Comi, Sandra Cook et al. · UCL Discovery (University College London) · 2009 · 10 citations

, , +17

1–4 of 4